← All trials
NCT00225095
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2005
- Primary completion
- Apr 1, 2008
- Completion date
- Apr 1, 2008
- First posted
- —
- Last posted
- —
- Enrollment
- 55
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Mesoblast, Inc.Lead sponsor
- University of Southern CaliforniaCollaborator
- Unlimited Research - San Antonio, TXCollaborator
- Triangle Orthopaedic Associates, P.A.Collaborator
- Orthopedic Center of Vero Beach - Vero Beach, FLCollaborator
- OrthoIndyCollaborator
- Greater Chesapeake Associates - Baltimore, MDCollaborator
- Rush UniversityCollaborator
- Osiris TherapeuticsStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.